# A Study of ABT-414 in Subjects With Solid Tumors

> **NCT01741727** · PHASE1 · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 57 (actual)

## Conditions studied

- Squamous Cell Tumors

## Interventions

- **DRUG:** ABT-414

## Key facts

- **NCT ID:** NCT01741727
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2017-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01741727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01741727, "A Study of ABT-414 in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01741727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*